
Keywords: AMY, amygdala; D1Rs, dopamine D1 receptors; D2Rs, dopamine D2 receptors; DARPP-32, dopamine and cyclic adenosine 3′,5′-monophosphate-regulated phosphoprotein-32; EDTA, ethylenediaminetetra acetic acid; EGTA, ethyleneglycoltetra acetic acid; HIP, hippocamp